A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells
10.1007/s10637-007-9085-0
Saved in:
Main Authors: | , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
2011
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/27208 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
id |
sg-nus-scholar.10635-27208 |
---|---|
record_format |
dspace |
spelling |
sg-nus-scholar.10635-272082023-10-29T21:37:46Z A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells Ma, B. Lam, K.C. Mo, F. Chan, A.T.C. Zee, B. Mok, T. Goh, B.C. Soo, R. Wang, L.Z. Tan, E.H. Leong, S.S. PHARMACOLOGY 3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine 10.1007/s10637-007-9085-0 Investigational New Drugs 26 2 169-173 2011-09-29T05:53:49Z 2011-09-29T05:53:49Z 2008 Article Ma, B., Lam, K.C., Mo, F., Chan, A.T.C., Zee, B., Mok, T., Goh, B.C., Soo, R., Wang, L.Z., Tan, E.H., Leong, S.S. (2008). A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells. Investigational New Drugs 26 (2) : 169-173. ScholarBank@NUS Repository. https://doi.org/10.1007/s10637-007-9085-0 01676997 http://scholarbank.nus.edu.sg/handle/10635/27208 000253765400007 Scopus |
institution |
National University of Singapore |
building |
NUS Library |
continent |
Asia |
country |
Singapore Singapore |
content_provider |
NUS Library |
collection |
ScholarBank@NUS |
topic |
3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine |
spellingShingle |
3-AP Gemcitabine Methemoglobinemia Non-small-cell lung cancer Triapine Ma, B. Lam, K.C. Mo, F. Chan, A.T.C. Zee, B. Mok, T. Goh, B.C. Soo, R. Wang, L.Z. Tan, E.H. Leong, S.S. A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells |
description |
10.1007/s10637-007-9085-0 |
author2 |
PHARMACOLOGY |
author_facet |
PHARMACOLOGY Ma, B. Lam, K.C. Mo, F. Chan, A.T.C. Zee, B. Mok, T. Goh, B.C. Soo, R. Wang, L.Z. Tan, E.H. Leong, S.S. |
format |
Article |
author |
Ma, B. Lam, K.C. Mo, F. Chan, A.T.C. Zee, B. Mok, T. Goh, B.C. Soo, R. Wang, L.Z. Tan, E.H. Leong, S.S. |
author_sort |
Ma, B. |
title |
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells |
title_short |
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells |
title_full |
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells |
title_fullStr |
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells |
title_full_unstemmed |
A multicenter phase II trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, Triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells |
title_sort |
multicenter phase ii trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-ap, triapine®) and gemcitabine in advanced non-small-cell lung cancer with pharmacokinetic evaluation using peripheral blood mononuclear cells |
publishDate |
2011 |
url |
http://scholarbank.nus.edu.sg/handle/10635/27208 |
_version_ |
1781410580009058304 |